Latest Sanofi Stories
Minerva president Rogerio Vivaldi and board chairman Marc Beer leading strategy to advance pipeline of novel therapies targeting applications in neuropsychiatry. CAMBRIDGE, Mass., March 5,
LYON, France, March 3, 2014 /PRNewswire/ -- - Sanofi Pasteur works with global partners to make available unparalleled quantities of affordable
ChinaMarketResearchReports.com adds Latest Report on “Investigation Report on China Insulin Glargine Market, 2009-2018” to its store. Dallas, TX (PRWEB)
DUBLIN, Feb. 28, 2014 /PRNewswire/ -- Actavis plc (NYSE: ACT) today confirmed that it has filed an Abbreviated New Drug Application (ANDA) with the U.S.
Talks by Holopack and Sanofi will highlight innovative software solutions supporting environmental monitoring and externalized collaboration; Accelrys to address mobile initiatives in the lab
- Fourth quarter 2013 EYLEA® (aflibercept) Injection global net sales were $586 million, consisting of $402 million in the U.S. and $184 million in rest of world(1) TARRYTOWN, N.Y., Feb.
Strategic Business Leader Brings Complementary Product Commercialization and Rare Disease Expertise SAN DIEGO, Feb.
-Regulus to Develop microRNA-21 for Alport Syndrome, a Life-Threatening Orphan Kidney Disease, and microRNA-21 in Oncology, to Human Proof-of-Concept- LA JOLLA, Calif.,